u/julia_erdogan

This is correct.

Disagree on that part. 99.2% and 98.1% on the same vial is normal.

Strongly agree. Jurisdiction matters.

The telehealth + compounding combo cost compounding plus 9% markup. Not cheap but covered by insurance depending on state.

telehealth costs shortage list plus compounding markup, total varies

stopper coring on the 6th draw because you keep using the same entry point. rotate.

API source questions are on-topic and compounders dodging them is newsworthy

Dead space in the needle hub holds a small but non-trivial volume.

Disagree on that part. 99.2% and 98.9% on the same vial is normal.

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

swirl, do not shake, or you are courting oxidation

Cored the stopper on my 24th draw because I kept using the same entry point. Rotate the puncture site.

Reconstituted at 2mL when I meant 2mL. Caught it because the units looked wrong. Write the concentration.

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

This is correct. 3mL versus 17mL is the common mistake.

telehealth prescriber models exist, pricing differs by state

u-100 syringe, not u-40, or your math is off by factor of 15

state board rules differ, say which state

the Poland import rules are specific to Poland

Not to be pedantic but jurisdiction and seizure are being used interchangeably and they are not interchangeable in real life.

Yeah, Poland rules are not global.